HealthDay - WEDNESDAY, Feb. 3 (HealthDay News) -- Adding a new drug to the
heavy regimen of immunosuppressant drugs given to organ transplant
recipients not only prevented rejection of the new organ but also cut down
on the amount of immunosuppressant drugs needed, a new study finds.